Skip to content
Triangle logo TriangleGet started
← Acute Myeloid Leukemia

HEALTH PROFESSIONAL · SOURCE READING

Intensive salvage chemotherapy

Source: Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 14, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Refractory or Recurrent AML / Chemotherapy

A number of intensive salvage chemotherapy regimens have demonstrated efficacy in recurrent AML, including:

Continue within this section

Fludarabine, cytarabine, and filgrastim (FLAG) →Mitoxantrone, etoposide, and cytarabine (MEC) →Standard or high-dose cytarabine and mitoxantrone →High-dose etoposide and cyclophosphamide →Idarubicin and cytarabine →Other intensive regimens →

Preserved source evidence · Not medical advice